Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative analyses of biomarkers and pathways for heart failure. | BMC Med Genomics | 2022 | 35346191 | PubTator, text mining | PubMed |
| CircTHBS1 drives gastric cancer progression by increasing INHBA mRNA expression and stability in a ceRNA- and RBP-dependent manner. | Cell Death Dis | 2022 | 35338119 | PubTator, text mining | PubMed |
| HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer. | Front Genet | 2022 | 35330734 | PubTator, text mining | PubMed |
| Preclinical Evaluation of BMP-9-Treated Human Bone-like Substitutes for Alveolar Ridge Preservation following Tooth Extraction. | Int J Mol Sci | 2022 | 35328724 | PubTator, text mining | PubMed |
| At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy. | Cancers (Basel) | 2022 | 35326728 | PubTator, text mining | PubMed |
| In Vitro Analysis of TGF-β Signaling Modulation of Porcine Alveolar Macrophages in Porcine Circovirus Type 2b Infection. | Vet Sci | 2022 | 35324828 | PubTator, text mining | PubMed |
| Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1/5/8 and NF-κB pathways. | Vascul Pharmacol | 2022 | 35318164 | PubTator, text mining | PubMed |
| What's new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors. | J Pathol Transl Med | 2022 | 35306778 | PubTator, text mining | PubMed |
| Obesity and exercise training alter inflammatory pathway skeletal muscle small extracellular vesicle microRNAs. | Exp Physiol | 2022 | 35293040 | PubTator, text mining | PubMed |
| Temporomandibular joint ankylosis-"Knowing when not to operate": Case report and qualitative systematic review of literature. | Clin Case Rep | 2022 | 35280078 | PubTator, text mining | PubMed |
| Bone morphogenetic protein receptor 1α promotes osteolytic lesion of oral squamous cell carcinoma by SHH-dependent osteoclastogenesis. | Cancer Sci | 2022 | 35279920 | PubTator, text mining | PubMed |
| Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva. | Bioorg Med Chem Lett | 2022 | 35276359 | PubTator, text mining | PubMed |
| [Progressive myositis ossificans: Case report]. | Rev Med Inst Mex Seguro Soc | 2022 | 35274918 | PubTator, text mining | PubMed |
| Hepcidin in hepatocellular carcinoma. | Br J Cancer | 2022 | 35264787 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence. | Clin Exp Otorhinolaryngol | 2022 | 35255661 | PubTator, text mining | PubMed |
| Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva. | Orphanet J Rare Dis | 2022 | 35246171 | PubTator, text mining | PubMed |
| MicroRNA-137 inhibits the inflammatory response and extracellular matrix degradation in lipopolysaccharide-stimulated human nucleus pulposus cells by targeting activin a receptor type I. | Bioengineered | 2022 | 35236255 | PubTator, text mining | PubMed |
| Epigenetic Biomarkers Screening of Non-Coding RNA and DNA Methylation Based on Peripheral Blood Monocytes in Smokers. | Front Genet | 2022 | 35233217 | PubTator, text mining | PubMed |
| Identification of cell type specific ACE2 modifiers by CRISPR screening. | PLoS Pathog | 2022 | 35231079 | PubTator, text mining | PubMed |
| Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans. | Clin Transl Immunology | 2022 | 35228871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=35